English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduAdvanced radiotherapy technology could safely deliver curative treatment for some prostate cancer patients in just one or two weeks, according to new research published today.
Tag: prostate cancer
New SU2C teams accelerate clinical trials for difficult breast & prostate cancers
LOS ANGELES – Stand Up To Cancer (SU2C) is launching teams of experts to lead innovative attacks on two types of cancer that have defied conventional treatment: triple-negative breast cancer (TNBC) in women and metastatic prostate cancer in men. The…
Pre-salvage RT PSA predictive of hormone therapy benefit with salvage RT for recurrent prostate cancer
Pre-salvage RT PSA is predictive of hormone therapy benefit with salvage RT for men with recurrent prostate cancer on NRG oncology trial
Search tightens for genes driving prostate cancer
The National Cancer Institute (NCI) is set up to fund individual projects in fields like genomics, computational biology, and pathology. Now researchers at University of Colorado Cancer Center are taking advantage of an innovative new program in cancer systems biology…
New blood test for prostate cancer is highly-accurate and avoids invasive biopsies
A new and simple blood test has been found to efficiently and accurately detect the presence of aggressive prostate cancer, according to research by Queen Mary University of London. In combination with the current prostate specific antigen (PSA) test, the…
Eating mushrooms may help lower prostate cancer risk
A new study published in the International Journal of Cancer found an inverse relationship between mushroom consumption and the development of prostate cancer among middle-aged and elderly Japanese men, suggesting that regular mushroom intake might help to prevent prostate cancer.…
Obesity and psychosocial well-being among patients with cancer
In a study published in Psycho-Oncology , excess weight was linked with poorer psychosocial health among older adults diagnosed with breast cancer or prostate cancer. The association was not seen in older patients with colon cancer, however. In the study…
UTA scientist explores using nanoparticles to reduce size of deep-seated tumors
Another collaborative project from a nanoparticles expert at The University of Texas at Arlington has yielded promising results in the search for more effective, targeted cancer treatments. Wei Chen, in collaboration with colleagues from the University of Rhode Island and…
LSU Health New Orleans awarded $13.6 million for expanded cancer clinical trials network
New Orleans, LA – LSU Health New Orleans has been awarded a $13.6 million grant by the National Cancer Institute to expand its successful statewide clinical trials network with a special emphasis on minority and underserved cancer patients. Principal Investigator…
Blocking specific protein could provide new treatment for deadly form of prostate cancer
Study provides rationale for clinical trial evaluating CDK7 inhibitors
A dual imaging approach may improve diagnosis and monitoring of prostate cancer
A new platform that combines two established imaging methods can peer into both the structure and molecular makeup of the prostate in men with prostate cancer. The technology is more sensitive and comprehensive compared to current “gold standard” methods, indicating…
Gold nanoparticles shown to be safe and effective treatment for prostate cancer
Biocompatible gold nanoparticles designed to convert near-infrared light to heat have been shown to safely and effectively ablate low- to intermediate-grade tumors within the prostate, according to a study conducted at the Icahn School of Medicine and published in the…
Gold nanoparticles shown to be safe and effective treatment for prostate cancer
Biocompatible gold nanoparticles designed to convert near-infrared light to heat have been shown to safely and effectively ablate low- to intermediate-grade tumors within the prostate, according to a study conducted at the Icahn School of Medicine and published in the…
Quest for new cancer treatment crosses milestone
Therapy invented at Rice University excels in pilot clinical trials
SOFIE And University Clinic Heidelberg Sign License Agreement For Theranostics That Target Cancer Associated Fibroblasts
LOS ANGELES and HEIDELBERG, Germany, June 21, 2019 /PRNewswire/ — SOFIE Inc. (SOFIE), a Theranostics company, is pleased to announce an exclusive global license with University Clinic Heidelberg (UKHD) for a class of molecular targeted diagnostics and radiotherapeutics (“theranostics”) that are…